APA (7th ed.) Citation

Topkan E, Selek U, Kucuk A, & Pehlivan B. (2022). Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas. Dove Medical Press.

Chicago Style (17th ed.) Citation

Topkan E, Selek U, Kucuk A, and Pehlivan B. Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas. Dove Medical Press, 2022.

MLA (9th ed.) Citation

Topkan E, et al. Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas. Dove Medical Press, 2022.

Warning: These citations may not always be 100% accurate.